UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000022450 |
|---|---|
| Receipt number | R000025874 |
| Scientific Title | Phase II study of Capecitabine + oxaliplatin(CapeOx) for elderly patients with untreated metastatic gastric cancer <TCOG GI-1601> |
| Date of disclosure of the study information | 2016/05/25 |
| Last modified on | 2023/01/11 10:25:48 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2016/05/25 14:14:25 | ||
| 2 | Update | 2016/05/25 14:39:34 | Key secondary outcomes Key secondary outcomes |
|
| 3 | Update | 2016/08/03 09:15:17 | Recruitment status |
|
| 4 | Update | 2018/05/31 09:39:03 | Interventions/Control_1 Interventions/Control_1 Key exclusion criteria Key exclusion criteria |
|
| 5 | Update | 2019/07/03 10:37:02 | Date of IRB Last follow-up date |
|
| 6 | Update | 2019/11/27 12:46:20 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Organization Organization Zip code Last name of contact person Last name of contact person Division name Division name Zip code Organization1 Address1 Tel1 Email1 Organization Organization Address Address Tel |
|
| 7 | Update | 2020/07/07 13:15:12 | Recruitment status |
|
| 8 | Update | 2022/05/30 13:22:07 | Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 9 | Update | 2023/01/11 10:25:48 | Recruitment status |
